CHEBI:85542 - egualen

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name egualen
ChEBI ID CHEBI:85542
Definition A member of the class of azulenes carrying sulfo, ethyl and isopropyl substituents at positions 1, 3 and 7 respectively. Used (in the form of its sodium salt) for treatment of gastric ulcers.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C15H18O3S
Net Charge 0
Average Mass 278.36700
Monoisotopic Mass 278.09767
InChI InChI=1S/C15H18O3S/c1-4-11-9-15(19(16,17)18)14-8-12(10(2)3)6-5-7-13(11)14/h5-10H,4H2,1-3H3,(H,16,17,18)
InChIKey NARQSHREEUXZBT-UHFFFAOYSA-N
SMILES CCc1cc(c2cc(cccc12)C(C)C)S(O)(=O)=O
Roles Classification
Biological Role(s): thromboxane A2 antagonist
An antagonist that binds to and deactivates thromboxane A2 receptors.
Application(s): anti-ulcer drug
One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing egualen (CHEBI:85542) has role anti-ulcer drug (CHEBI:49201)
egualen (CHEBI:85542) has role thromboxane A2 antagonist (CHEBI:85540)
egualen (CHEBI:85542) is a arenesulfonic acid (CHEBI:33555)
egualen (CHEBI:85542) is a azulenes (CHEBI:38096)
egualen (CHEBI:85542) is conjugate acid of egualen(1−) (CHEBI:85546)
Incoming egualen(1−) (CHEBI:85546) is conjugate base of egualen (CHEBI:85542)
IUPAC Name
3-ethyl-7-(propan-2-yl)azulene-1-sulfonic acid
INNs Sources
egualen ChemIDplus
egualene ChemIDplus
egualeno ChemIDplus
egualenum ChemIDplus
Synonyms Sources
3-Ethyl-7-isopropyl-1-azulenesulfonic acid ChemIDplus
3-ethyl-7-isopropylazulene-1-sulfonic acid ChEBI
Azuletil ChemIDplus
Manual Xref Database
993 DrugCentral
View more database links
Registry Numbers Types Sources
13495833 Reaxys Registry Number Reaxys
99287-30-6 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
10611135 PubMed citation Europe PMC
11729358 PubMed citation Europe PMC
1829059 PubMed citation Europe PMC
2258126 PubMed citation Europe PMC
23568973 PubMed citation Europe PMC
2595296 PubMed citation Europe PMC
9027640 PubMed citation Europe PMC
Last Modified
22 February 2017